David Roman
Stock Analyst at Goldman Sachs
(2.81)
# 1,679
Out of 5,124 analysts
59
Total ratings
42.42%
Success rate
0.8%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $24.39 | +2.50% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $81.11 | -12.46% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $96.05 | +15.56% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $180 → $202 | $175.22 | +15.28% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $85.33 | +21.88% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $19.50 | +12.82% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $29.25 | +12.82% | 3 | Oct 29, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $16.58 | -3.50% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $110.72 | -6.97% | 1 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $43.29 | +47.84% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $14.37 | +39.18% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $11.63 | +63.37% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $14.90 | +94.63% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $104 | $91.07 | +14.20% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $282.92 | +34.31% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $90.02 | +15.53% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $7.05 | +41.84% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $82.82 | -0.99% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $124.19 | +24.00% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $21.55 | +11.37% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $79.02 | -10.15% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $60.67 | -9.35% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $348.18 | +22.64% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $94.71 | -4.97% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $561.98 | -11.03% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $194.94 | +40.56% | 1 | May 30, 2024 |
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $24.39
Upside: +2.50%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $81.11
Upside: -12.46%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $96.05
Upside: +15.56%
iRhythm Technologies
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $175.22
Upside: +15.28%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $85.33
Upside: +21.88%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $19.50
Upside: +12.82%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $29.25
Upside: +12.82%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.58
Upside: -3.50%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $110.72
Upside: -6.97%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $43.29
Upside: +47.84%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $14.37
Upside: +39.18%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $11.63
Upside: +63.37%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $14.90
Upside: +94.63%
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $91.07
Upside: +14.20%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $282.92
Upside: +34.31%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $90.02
Upside: +15.53%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.05
Upside: +41.84%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $82.82
Upside: -0.99%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $124.19
Upside: +24.00%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $21.55
Upside: +11.37%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $79.02
Upside: -10.15%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $60.67
Upside: -9.35%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $348.18
Upside: +22.64%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $94.71
Upside: -4.97%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $561.98
Upside: -11.03%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $194.94
Upside: +40.56%